ANGN Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2022-07-01 | Goldberg Itzhak | director | 1,687,986 | F-InKind | D | 32,082 | 1.12 | 35,931.84 |
| 2022-06-09 | OMENN GILBERT S | director | 15,000 | A-Award | A | 15,000 | 1.73 | 25,950.00 |
| 2022-06-09 | WILSON KAREN J | director | 15,000 | A-Award | A | 15,000 | 1.73 | 25,950.00 |
| 2022-06-09 | Nissenson Allen | director | 15,000 | A-Award | A | 15,000 | 1.73 | 25,950.00 |
| 2022-06-09 | GANZI VICTOR F | director | 15,000 | A-Award | A | 15,000 | 1.73 | 25,950.00 |
| 2022-05-25 | Venkatesan Jay | director, officer: | 1,891,947 | P-Purchase | A | 11,313 | 1.25 | 14,102.79 |
| 2022-05-24 | Venkatesan Jay | director, officer: President and Chief Executive Officer and Director | 1,721,457 | P-Purchase | A | 32,200 | 1.24 | 39,928.00 |
| 2022-05-20 | Venkatesan Jay | director, officer: President and Chief Executive Officer and Director | 1,689,257 | P-Purchase | A | 50,000 | 1.23 | 61,500.00 |
| 2022-05-20 | Nissenson Allen | director | 9,383 | P-Purchase | A | 2,037 | 1.18 | 2,403.66 |
| 2022-05-19 | Nissenson Allen | director | 7,346 | P-Purchase | A | 7,346 | 1.16 | 8,521.36 |
| 2022-03-03 | Venkatesan Jay | officer: President and Chief Executive Officer | 760,000 | A-Award | A | 160,000 | 1.94 | 310,400.00 |
| 2022-03-03 | Venkatesan Jay | officer: President and Chief Executive Officer | 600,000 | A-Award | A | 600,000 | 1.94 | 1,164,000.00 |
| 2022-03-02 | CURHAN GREGORY S | officer: Chief Financial Officer | 100,000 | A-Award | A | 100,000 | 1.99 | 199,000.00 |
| 2022-03-02 | Rhodes Jennifer J | officer: Executive Vice President, Chief Business Officer, General Counsel, Chief Compliance Officer and Secretary | 275,000 | A-Award | A | 100,000 | 1.99 | 199,000.00 |
| 2022-03-02 | Rhodes Jennifer J | officer: Executive Vice President, Chief Business Officer, General Counsel, Chief Compliance Officer and Secretary | 175,000 | A-Award | A | 175,000 | 1.99 | 348,250.00 |
| 2022-03-02 | Neylan John F. | officer: Executive Vice President, Chief Medical Officer and Head of Research | 275,000 | A-Award | A | 100,000 | 1.99 | 199,000.00 |
| 2022-03-02 | Neylan John F. | officer: Executive Vice President, Chief Medical Officer and Head of Research | 175,000 | A-Award | A | 175,000 | 1.99 | 348,250.00 |
| 2021-12-28 | Venkatesan Jay | director, officer: President and Chief Executive Officer and Director | 1,639,257 | P-Purchase | A | 210,337 | 2.66 | 559,853.99 |
| 2021-12-27 | Venkatesan Jay | director, officer: President and Chief Executive Officer and Director | 1,428,920 | P-Purchase | A | 66,907 | 2.55 | 170,519.18 |
| 2021-12-20 | Venkatesan Jay | director, officer: President and Chief Executive Officer and Director | 1,362,013 | P-Purchase | A | 3,527 | 2.54 | 8,975.86 |
| 2021-12-20 | Neylan John F. | officer: Senior Vice President and Chief Medical Officer | 35,136 | S-Sale | D | 358 | 2.62 | 938.00 |
| 2021-12-17 | Venkatesan Jay | director, officer: President and Chief Executive Officer and Director | 1,358,486 | P-Purchase | A | 13,742 | 2.54 | 34,958.27 |
| 2021-12-16 | Venkatesan Jay | director, officer: President and Chief Executive Officer and Director | 1,344,744 | P-Purchase | A | 27,883 | 2.55 | 70,992.91 |
| 2021-12-15 | Venkatesan Jay | director, officer: President and Chief Executive Officer and Director | 1,316,861 | P-Purchase | A | 77,604 | 2.41 | 186,955.80 |
| 2021-12-15 | CURHAN GREGORY S | officer: Interim Chief Financial Officer | 4,000 | P-Purchase | A | 4,000 | 2.37 | 9,480.00 |
| 2021-12-14 | Rhodes Jennifer J | officer: Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary | 30,399 | S-Sale | D | 451 | 2.42 | 1,090.11 |
| 2021-12-06 | Goldberg Itzhak | director, officer: Executive Chairman and Chief Scientific Officer | 1,720,068 | S-Sale | D | 32,118 | 3.35 | 107,720.56 |
| 2021-12-03 | Goldberg Itzhak | director, officer: Executive Chairman and Chief Scientific Officer | 1,752,186 | S-Sale | D | 40,215 | 3.39 | 136,216.25 |
| 2021-12-02 | Goldberg Itzhak | director, officer: Executive Chairman and Chief Scientific Officer | 1,792,401 | S-Sale | D | 38,800 | 3.51 | 136,327.68 |
| 2021-12-01 | Goldberg Itzhak | director, officer: Executive Chairman and Chief Scientific Officer | 1,831,201 | S-Sale | D | 38,867 | 3.54 | 137,666.91 |
| 2021-11-18 | Neylan John F. | officer: Senior Vice President and Chief Medical Officer | 35,494 | S-Sale | D | 374 | 4.13 | 1,544.62 |
| 2021-11-16 | Goldberg Itzhak | officer: Executive Chairman and Chief Scientific Officer | 1,870,068 | S-Sale | D | 38,495 | 4.26 | 163,807.77 |
| 2021-11-15 | Goldberg Itzhak | officer: Executive Chairman and Chief Scientific Officer | 1,908,563 | S-Sale | D | 111,505 | 4.17 | 465,243.46 |
| 2021-11-15 | Rhodes Jennifer J | officer: Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary | 30,850 | S-Sale | D | 433 | 4.40 | 1,905.20 |
| 2021-10-18 | Neylan John F. | officer: Senior Vice President and Chief Medical Officer | 35,868 | S-Sale | D | 373 | 8.62 | 3,215.26 |
| 2021-10-14 | Rhodes Jennifer J | officer: Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary | 31,283 | S-Sale | D | 430 | 8.65 | 3,719.50 |
| 2021-09-20 | Neylan John F. | officer: Senior Vice President and Chief Medical Officer | 36,241 | S-Sale | D | 376 | 10.07 | 3,786.32 |
| 2021-09-14 | Rhodes Jennifer J | officer: See Remarks | 31,713 | S-Sale | D | 430 | 10.64 | 4,575.20 |
| 2021-08-31 | EISA-ABC LLC | 10 percent owner | 2,740,978 | J-Other | D | 913,659 | 0.00 | 0.00 |
| 2021-08-18 | Neylan John F. | officer: See Remarks | 36,617 | S-Sale | D | 381 | 9.03 | 3,440.43 |
| 2021-08-16 | Rhodes Jennifer J | officer: See Remarks | 32,143 | S-Sale | D | 445 | 10.68 | 4,752.60 |
| 2021-07-21 | Rhodes Jennifer J | officer: See Remarks | 32,588 | S-Sale | D | 432 | 10.94 | 4,726.08 |
| 2021-07-21 | Neylan John F. | officer: See Remarks | 36,998 | S-Sale | D | 365 | 10.98 | 4,007.70 |
| 2021-07-14 | Rhodes Jennifer J | officer: See Remarks | 32,589 | S-Sale | D | 431 | 11.01 | 4,745.31 |
| 2021-06-24 | Venkatesan Jay | director, officer: President and Chief Executive Officer and Director | 1,239,257 | F-InKind | D | 41,091 | 13.78 | 566,233.98 |
| 2021-06-24 | Goldberg Itzhak | officer: Executive Chairman and Chief Scientific Officer | 2,020,068 | F-InKind | D | 47,410 | 13.78 | 653,309.80 |
| 2021-06-18 | Neylan John F. | officer: See Remarks | 37,363 | S-Sale | D | 366 | 13.20 | 4,831.20 |
| 2021-06-14 | Rhodes Jennifer J | officer: See Remarks | 33,020 | S-Sale | D | 427 | 13.27 | 5,666.29 |
| 2021-05-18 | Neylan John F. | officer: See Remarks | 37,729 | S-Sale | D | 363 | 13.91 | 5,049.33 |
| 2021-05-14 | Rhodes Jennifer J | officer: See Remarks | 33,447 | S-Sale | D | 440 | 13.92 | 6,124.80 |
| 2021-04-19 | Neylan John F. | officer: See Remarks | 38,092 | S-Sale | D | 381 | 0.00 | 0.00 |
| 2021-04-15 | Rhodes Jennifer J | officer: See Remarks | 33,887 | S-Sale | D | 399 | 15.01 | 5,988.99 |
| 2021-03-17 | Neylan John F. | officer: See Remarks | 38,453 | S-Sale | D | 442 | 19.13 | 8,455.46 |
| 2021-03-13 | Rhodes Jennifer J | officer: See Remarks | 34,286 | S-Sale | D | 499 | 20.45 | 10,204.55 |
| 2021-03-08 | Nissenson Allen | director | 15,000 | A-Award | A | 15,000 | 15.01 | 225,150.00 |
| 2021-03-08 | WILSON KAREN J | director | 15,000 | A-Award | A | 15,000 | 15.01 | 225,150.00 |
| 2021-03-08 | OMENN GILBERT S | director | 15,000 | A-Award | A | 15,000 | 15.01 | 225,150.00 |
| 2021-03-08 | GANZI VICTOR F | director | 15,000 | A-Award | A | 15,000 | 15.01 | 225,150.00 |
| 2021-02-13 | Rhodes Jennifer J | officer: See Remarks | 34,785 | S-Sale | D | 457 | 19.54 | 8,929.78 |
| 2021-02-09 | GANZI VICTOR F | director | 405,405 | C-Conversion | A | 18,741 | 11.57 | 216,833.37 |
| 2021-02-09 | GANZI VICTOR F | director | 823,117 | X-InTheMoney | A | 367,590 | 16.00 | 5,881,440.00 |
| 2021-02-09 | GANZI VICTOR F | director | 576,397 | S-Sale | D | 246,720 | 16.00 | 3,947,520.00 |
| 2021-02-09 | GANZI VICTOR F | director | 455,527 | C-Conversion | A | 50,122 | 11.57 | 579,911.54 |
| 2021-02-09 | GANZI VICTOR F | director | 0 | X-InTheMoney | D | 367,590 | 16.00 | 5,881,440.00 |
| 2021-02-09 | Goldberg Itzhak | officer: See Remarks | 2,067,478 | F-InKind | D | 38,353 | 16.00 | 613,648.00 |
| 2021-02-09 | OMENN GILBERT S | director | 42,152 | C-Conversion | A | 23,483 | 11.57 | 271,698.31 |
| 2021-02-09 | OMENN GILBERT S | director | 65,543 | C-Conversion | A | 23,391 | 11.57 | 270,633.87 |
| 2021-02-09 | OMENN GILBERT S | director | 80,326 | C-Conversion | A | 14,783 | 11.57 | 171,039.31 |
| 2021-02-09 | WILSON KAREN J | director | 18,718 | C-Conversion | A | 18,718 | 11.57 | 216,567.26 |
| 2021-02-09 | Venkatesan Jay | director, officer: See Remarks | 0 | X-InTheMoney | D | 237,152 | 6.43 | 1,524,887.36 |
| 2021-02-09 | Venkatesan Jay | director, officer: See Remarks | 1,202,111 | C-Conversion | A | 165,094 | 0.00 | 0.00 |
| 2021-02-09 | Venkatesan Jay | director, officer: See Remarks | 1,439,263 | X-InTheMoney | A | 237,152 | 6.43 | 1,524,887.36 |
| 2021-02-09 | Venkatesan Jay | director, officer: See Remarks | 1,037,017 | F-InKind | D | 31,966 | 16.00 | 511,456.00 |
| 2021-02-09 | Venkatesan Jay | director, officer: See Remarks | 0 | C-Conversion | D | 1,804 | 6.43 | 11,599.72 |
| 2021-02-09 | Venkatesan Jay | director, officer: See Remarks | 1,208,086 | S-Sale | D | 159,177 | 16.00 | 2,546,832.00 |
| 2021-02-09 | Venkatesan Jay | director, officer: See Remarks | 1,280,348 | C-Conversion | A | 262 | 11.57 | 3,031.34 |
| 2021-02-04 | Rhodes Jennifer J | officer: See Remarks | 70,012 | A-Award | A | 70,012 | 16.00 | 1,120,192.00 |
| 2021-02-04 | Venkatesan Jay | director, officer: See Remarks | 178,920 | A-Award | A | 178,920 | 16.00 | 2,862,720.00 |
| 2021-02-04 | Goldberg Itzhak | officer: See Remarks | 70,012 | A-Award | A | 70,012 | 16.00 | 1,120,192.00 |
| 2021-02-04 | Neylan John F. | officer: See Remarks | 70,012 | A-Award | A | 70,012 | 16.00 | 1,120,192.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.